Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tianma Weifen Capsules is a traditional Chinese medicine (TCM) product manufactured by Yunnan Yongzitang, a subsidiary of Hunan Hansen Pharmaceutical. The formulation consists of finely powdered *Gastrodia elata* (Tianma), a herb traditionally used in Chinese medicine to "extinguish wind" and "calm the liver." It is primarily indicated for the treatment of headaches, dizziness, numbness of the limbs, and convulsions. As a traditional herbal product, its therapeutic effects are attributed to the complex mixture of natural constituents within the plant material, such as gastrodin, rather than a single defined molecular target. The product is approved and commercially available in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tianma Weifen Capsules.